Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4203690 | 0.83 | CYP2D6 (0.36) | CYP2D6 | |
| SCHEMBL26289081 | 0.79 | EPHX1 (0.36) | TSHREPHX1 | |
| SCHEMBL943365 | 0.78 | TSHR (0.48) | MEN1ALDH1A1CYP3A4TSHRMAPK1 | |
| SCHEMBL7290051 | 0.78 | CYP2D6 (0.33) | CYP2D6KMT2A | |
| SCHEMBL571410 | 0.76 | TDP1 (0.46) | MEN1ALDH1A1TSHRKMT2AEPHX1 | |
| SCHEMBL892213 | 0.76 | TGFBR1 (0.32) | ALDH1A1 | |
| SCHEMBL9970722 | 0.75 | MAPT (0.55) | MEN1MAPTTSHRMAPK1KMT2A | |
| SCHEMBL2422187 | 0.74 | — | — | |
| SCHEMBL28059282 | 0.73 | FAAH (0.46) | ALDH1A1 | |
| SCHEMBL2824552 | 0.73 | BCHE (0.36) | L3MBTL1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346705-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND POLYCYANOACETATE | SIKA TECHNOLOGY AG (CH) | 2025-11-13 | — | — | US | disclosed |
| EP-4554995-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND 1,3 KETO ESTER | Sika Technology AG (CH) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024012828-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND 1,3 KETO ESTER | SIKA TECHNOLOGY AG (CH) | 2024-01-18 | — | — | WO | disclosed |
| US-8430989-B2 | Hydroxyaldimine-containing polyurethane composition | SIKA TECHNOLOGY AG (CH) | 2013-04-30 | — | — | US | disclosed |
| US-20110214810-A1 | HYDROXYALDIMINE-CONTAINING POLYURETHANE COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110214810-A1 | HYDROXYALDIMINE-CONTAINING POLYURETHANE COMPOSITION | ADH1A, ODC1, ADH1C | L3MBTL1 3097/4885MEN1 785/4885USP2 2820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.